# Noninterventional Study Assessing Cognitive Function and Physical Activity in People With Multiple Sclerosis

> **NCT01491100** · — · COMPLETED · sponsor: **Bayer** · enrollment: 1085 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Interferon beta-1b (Betaseron, BAY86-5046)

## Key facts

- **NCT ID:** NCT01491100
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04-30
- **Primary completion:** 2016-12-22
- **Final completion:** 2017-04-05
- **Target enrollment:** 1085 (ACTUAL)
- **Last updated:** 2018-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01491100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01491100, "Noninterventional Study Assessing Cognitive Function and Physical Activity in People With Multiple Sclerosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01491100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*